TY - JOUR
T1 - Hypophosphatasia
T2 - Pediatric forms
AU - Caswel, Alison M.
AU - Russell, R. Graham G.
AU - Whyte, Michael P.
N1 - Funding Information:
We gratefully acknowledge support from Action Research for the Crippled Child, U.K. (A.M. Caswell and R.G.G. Russell), and The Shriners Hospitals for Crippled Children, U.S.A. (M.P. Whyte).
PY - 1989/4
Y1 - 1989/4
N2 - Hypophosphatasia is an inborn error of metabolism characterized by deficient activity of the tissue nonspecific isoenzyme of alkaline phosphatase (TNSALP). Pediatricians encounter a perinatal, an infantile and a childhood form of the disease, but in all cases the predominant feature is defective mineralization. Clinical severity and classification generally reflect the age at which rickets develops. Patients with perinatal hypophosphatasia are stillborn or live only a few days. Infantile hypophosphatasia (onset within the first six months) causes dramatically reduced skeletal mineralization and systemic symptoms such as recurrent pneumonia, vomiting, convulsions and muscle weakness. Childhood hypophosphatasia results in rickets and premature loss of teeth. In children with an especially mild form of the disease, the mineralization defect is restricted to the teeth (odontohypophosphatasia). Study of the disease is also contributing significantly to knowledge of the biology of human TNSALP. Skin fibroblasts derived from patients provide an in vitro system for studies of hypophosphatasia.
AB - Hypophosphatasia is an inborn error of metabolism characterized by deficient activity of the tissue nonspecific isoenzyme of alkaline phosphatase (TNSALP). Pediatricians encounter a perinatal, an infantile and a childhood form of the disease, but in all cases the predominant feature is defective mineralization. Clinical severity and classification generally reflect the age at which rickets develops. Patients with perinatal hypophosphatasia are stillborn or live only a few days. Infantile hypophosphatasia (onset within the first six months) causes dramatically reduced skeletal mineralization and systemic symptoms such as recurrent pneumonia, vomiting, convulsions and muscle weakness. Childhood hypophosphatasia results in rickets and premature loss of teeth. In children with an especially mild form of the disease, the mineralization defect is restricted to the teeth (odontohypophosphatasia). Study of the disease is also contributing significantly to knowledge of the biology of human TNSALP. Skin fibroblasts derived from patients provide an in vitro system for studies of hypophosphatasia.
UR - http://www.scopus.com/inward/record.url?scp=0024356858&partnerID=8YFLogxK
U2 - 10.1515/JPEM.1989.3.2.73
DO - 10.1515/JPEM.1989.3.2.73
M3 - Article
AN - SCOPUS:0024356858
SN - 0334-018X
VL - 3
SP - 73
EP - 92
JO - Journal of Pediatric Endocrinology and Metabolism
JF - Journal of Pediatric Endocrinology and Metabolism
IS - 2
ER -